Stock Ratings / Health Care / XTNT / insiders

TELA (36) CVRX (43) SNWV (53) SRTS (46) ⌘ Pro Terminal →

Xtant Medical Holdings Inc. (XTNT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$0.29 +1.54% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.29

Xtant Medical Holdings Inc. (XTNT) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY) →

ROARABLE C+ • HOLD / WATCH Cap $40.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.29 (+0.09%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 7.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY • 57.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+3.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for XTNT)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (69/100 Composite)

🔍 WHY XTNT SCORES 69/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (23% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: Whale & Options Positioning+15/20 pts (22% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk12/20 pts (-8 pt drag)

Balance-sheet & 10-K footnote risk deducts 8 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B+$0.33-12.1% Next Q

Q2 (-2Q)

Grade B+$0.29-3.4% Next Q

Q3 (-1Q)

Grade B$0.28+3.6% Next Q

Current

Grade C+$0.29+2% Hist 90D α

Trajectory: B+ (77) → C+ (69)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the XTNT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 69/100 (C+) score, XTNT faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 60.4% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.33) or 200D SMA ($0.46) invalidates the momentum regime and cuts Target Base ($0.30) toward Bear Floor ($0.23).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $XTNT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “XTNT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 69%NO 31%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

XTNT Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (XTNT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on XTNT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (XTNT Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

XTNT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -44.23%🛡️ HOLDING TREND SUPPORT

2026-10-30O $0.28H $0.30L $0.28C $0.29VOL 44.5K

RES: $0.44SUP: $0.27SMA50: $0.33SMA200: $0.46

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

XTNT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 XTNT Butterfly Map → + Track XTNT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-15.0%/yr Implied 5Y Growth

vs. +14.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on XTNT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for XTNT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for XTNT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (XTNT)

Health Care Rank #104 of 1016 ⚔️ TELA vs XTNT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (XTNT vs. TELA, CVRX, SNWV, SRTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Xtant Medical Holdings Inc. (XTNT) ranks #104 by composite RQD confidence (69/100, grade C+) and #773 by equity capitalization ($40.7M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. XTNT currently leads its immediate peer cohort in composite quantitative strength at 69/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
XTNT ACTIVE Xtant Medical Holdings Inc.	C+	69/100	—	62.9%	12.8%	+1.54%	$40.7M	Benchmark Subject
TELA TELA Bio Inc.	D-	36/100	—	67.7%	-35.0%	-5.74%	$41.5M	/tela-vs-xtnt →
CVRX CVRx Inc.	D-	43/100	—	85.3%	-35.0%	+1.79%	$38.0M	/cvrx-vs-xtnt →
SNWV SANUWAVE Health Inc.	D+	53/100	3.8x	77.1%	67.3%	0.00%	$45.3M	/snwv-vs-xtnt →
SRTS Sensus Healthcare Inc.	D	46/100	—	43.2%	-31.3%	-1.77%	$45.6M	/srts-vs-xtnt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001453593

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Xtant Medical Holdings Inc. (XTNT) reported GAAP revenue of $133.9M (+14.2% vs. FY2024 revenue of $117.3M , and +46.7% cumulative change since FY2023) , GAAP net income of $5.0K, operating cash flow of $12.5M, and free cash flow of $10.2M (+163.5% YoY). On the balance sheet, XTNT closed FY2025 with $94.1M in total assets against $11.0M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$133.9M	$5.0K	$12.5M	$10.2M	$94.1M	$11.0M
FY2024 (FY)	2024-12-31	$117.3M	-$16.4K	-$11.9M	-$16.0M	$93.8M	$22.0M
FY2023 (FY)	2023-12-31	$91.3M	$660	-$9.5M	-$9.5M	—	—

3. XTNT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is XTNT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Xtant Medical Holdings Inc. (NYSE: XTNT) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $0.29 (+1.54% 1D, market cap $40.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, XTNT ranks #104 in composite RQD confidence.

How does XTNT compare to TELA and CVRX in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), XTNT carries a Roarable C+ (69/100 RQD), trailing P/E of N/A, gross margin of 62.9%, and ROIC of 12.8%. By comparison, TELA (TELA Bio Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $41.5M) and CVRX (CVRx Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $38.0M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for XTNT?

Per XTNT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001453593), Xtant Medical Holdings Inc. generated $133.9M in revenue (+14.2% YoY), $5.0K in net income, and $10.2M in free cash flow against $94.1M in total assets and $11.0M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is XTNT trading relative to its 50-day, 200-day, and 52-week technical levels?

XTNT last traded at $0.29 (+1.54% on volume of 38,463 shares), positioning the stock -12.12% below its 50-day simple moving average ($0.33) and -36.96% below its 200-day simple moving average ($0.46). Across its 52-week range of $0.27 to $0.89, XTNT sits at the 3.2% percentile with a 14-day RSI of 34.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.33).

XTNT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are XTNT insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies XTNT leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

Direct Sub-Reports: XTNT RQD Cockpit XTNT 12M Forecast XTNT Earnings & Move XTNT Dividends & DRIP XTNT Insiders & 13F XTNT Whale Options XTNT Profit Sankey XTNT News & Why